SCHEMBL2237620

SCHEMBL2237620

CN(C)Cc1cccc(NS(=O)(=O)c2ccc(-c3ncc(Cl)cn3)cc2)c1

nearest known ligand 0.51

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
LIMK2 P53671 5/20 0.51
HTR6 P50406 1/20 0.49
MAPT P10636 1/20 0.48
CYP19A1 P11511 1/20 0.47
LIMK1 P53667 3/20 0.46
ALOX15 P16050 1/20 0.46
CYP3A4 P08684 1/20 0.46
NMT1 P30419 6/20 0.45
HDAC4 P56524 1/20 0.44
HDAC1 Q13547 1/20 0.44
HDAC6 Q9UBN7 1/20 0.44
MEN1 O00255 1/20 0.43
PKM P14618 1/20 0.43
KMT2A Q03164 1/20 0.43
IKBKB O14920 1/20 0.43
PTGES O14684 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2235488 0.89 HTR6 (0.53) LIMK2HTR6MAPTLIMK1CYP3A4
SCHEMBL2238500 0.86 HTR6 (0.47) LIMK2HTR6MAPTCYP19A1LIMK1
SCHEMBL10093361 0.86 HTR6 (0.50) LIMK2HTR6MAPTCYP19A1LIMK1
SCHEMBL2237501 0.80 CYP19A1 (0.53) LIMK2HTR6MAPTCYP19A1LIMK1
SCHEMBL2305394 0.78 HTR6 (0.75) LIMK2HTR6LIMK1MEN1PKM
SCHEMBL2236047 0.78 HTR6 (0.59) LIMK2HTR6MAPTCYP19A1LIMK1
SCHEMBL2235116 0.75 HTR6 (0.58) LIMK2HTR6CYP19A1LIMK1IKBKB
SCHEMBL15232980 0.73 CYP19A1 (0.66) HTR6MAPTCYP19A1ALOX15CYP3A4
SCHEMBL13464202 0.72 MAPT (0.47) LIMK2HTR6MAPTCYP19A1ALOX15
SCHEMBL13028501 0.70 CYP19A1 (0.66) LIMK2HTR6MAPTCYP19A1ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2349990-B1 ARYL-PHENYL-SULFONAMIDE-PHENYLENE COMPOUNDS AND THEIR USE PIMCO 2664 LTD (GB) 2018-05-02 EP disclosed
EP-2349990-B1 ARYL-PHENYL-SULFONAMIDE-PHENYLENE COMPOUNDS AND THEIR USE PIMCO 2664 LTD (GB) 2018-05-02 EP disclosed
US-8207167-B2 Aryl-phenyl-sulfonamide-phenylene compounds and their use PIMCO 2664 LIMITED (GB) 2012-06-26 US disclosed
US-8207167-B2 Aryl-phenyl-sulfonamide-phenylene compounds and their use PIMCO 2664 LIMITED (GB) 2012-06-26 US disclosed
US-20110190302-A1 Aryl-Phenyl-Sulfonamide-Phenylene Compounds and Their Use PIMCO 2664 LIMITED (GB) 2011-08-04 US disclosed
US-20110190302-A1 Aryl-Phenyl-Sulfonamide-Phenylene Compounds and Their Use PIMCO 2664 LIMITED (GB) 2011-08-04 US disclosed
WO-2010032010-A1 ARYL-PHENYL-SULFONAMIDE-PHENYLENE COMPOUNDS AND THEIR USE PIMCO 2664 LIMITED (GB) 2010-03-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110190302-A1 Aryl-Phenyl-Sulfonamide-Phenylene Compounds and Their Use SOST, PSAP, ARSA LIMK2 3017/4885HTR6 4577/4885MAPT 633/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.